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Smar To improve our understanding of the relationship and possible associations between human
papillomavirus (HPV) infection and the development of cervcal malignancies, the presence of multiple types
of HPV DNA sequences in cervical carcinoma was determined in Chinese citizens living in two different
geographical locations where the incidences of cervical carcinoma are either relatively low or extremely high.
HPV DNA sequences were found in 88.5% (54 of61) of Chinese cervical carcinoma patients living in Taiwan,
where the prevalence of cervical carcinoma is 23.7 per 100,000 women. In contrast, in LueYang in Shanxi
province, an area with a very high prevaknce of cervical carcinoma (1,026 per 100,000 women), only 57.1%
(28 of 49) of Chinese cervical carcinoma patients were found to be infected with genital HPV. This result
seems to suggest that either the presence of HPV may have different implications in different populations or
HPV infection may not be the only factor that determines the development of cervical carcinoma, at least in
certain geographical areas. Recently acquired transient or chronic persistent HPV infection may have a
different outcome with regard to cervical carcinogenesis. Alternatively, other factors, such as host deter-
minants, may play a role in the development of cervical carcinoma.
Certain types of human papillomaviruses (HPVs) have been
implicated as one of the major risk factors in the develop-
ment of malignancies of the uterine cervix in women
(Howley, 1991). DNA-based analyses have consistently re-
vealed a high prevalence of HPV 16 and 18 DNA sequences
in cervical carcinomas (Gissmann, 1984; Brescia et al., 1986;
Pfister, 1987; Xiao et al., 1988; Arends et al., 1990). How-
ever, factors other than HPV infections, such as host factors,
have also been suggested to play important roles in the
carcinogenesis of cervical carcinoma (zur Hausen, 1991).
The prevalence of and mortality from cervical carcinomas
among Chinese women living in Taiwan have been reported
to be 23.7 and 6.15 per 100,000 women respectively
(Reported Cancer Incidence, 1988). Although Chinese living
in mainland China have a very low rate of venereal disease
(Wegman et al., 1973; Committee on Scholarly Communica-
tion with the People's Republic of China, 1981), central
China has one of the highest rates of cervical carcinoma in
the world (Scherer, 1983; Peto & Hausen, 1986). For
example, the prevalence of cervical carcinoma in LueYang in
the Shanxi province of China is 1,026 per 100,000 women
based on an epidemiological survey of 12,980 women resi-
dents conducted in 1983 (Zhang et al., 1986). The mortality
resulting from cervical carcinoma in LueYang was 54.5 per
100,000 women (Zhang et al., 1986). Both of these figures
were the highest among all counties in China.
We report in the following text our examination and
analysis of the presence of multiple types of HPV DNA
sequences in cervical carcinoma tissues of Chinese patients
living in Taiwan and LueYang, where the prevalence of
cervical carcinoma is relatively low or extremely high.
MateriaL ad mwthods
Patients and cervical carcinoma tissues
Cervical carcinoma tissue sections from 61 Chinese patients
living in Taiwan (where the prevalence of cervical carcinoma
is relatively low) and from 49 Chinese patients living in
LueYang in the Shanxi province of China (where the preva-
lence of cervical carcinoma is extremely high) were the sub-
jects of this investigation. These tissue sections were prepared
from either fresh-frozen or paraffin blocks with disposable
blades to avoid any cross-contamination of HPV.
Determination ofthe presence ofHP V DNA sequences
Two consecutive 5 iLm sections were cut from each of the
paraffin blocks. One section was used for histopathological
evaluation after staining (haematoxylin and eosin) and one
for the extraction of total DNA with phenol and chloroform.
The DNA was further purified by alcohol precipitation and
then used for the determination of the presence of HPV
DNA sequences by in vitro DNA amplification with consen-
sus primers MY09 and MYl purchased from Perkin-Elmer
Cetus (Norwalk, CT, USA). These primers are capable of
amplifying DNA from LI ORF of genital HPV types 6, 11,
16, 18, 30, 31, 33, 35, 39, 40, 42, 43, 45, 51, 52, 53, 54, 55, 57,
58, 59 and from at least another 20 others as yet undeter-
mined HPV types (Bauer et al., 1991). Dermal HPV types 1,
5, 8, 26, 27, 41, 47 and 48 are also amplified with these
primers. The sequences of the oligonucleotide primers were
CGTCCMARRGAWACTGATC and GCMCAGG-
WCATAAYAATGG (where M = A + C, R = A + G, W =
A + T, Y = C + T). DNA samples, deoxyribonucleoside
triphosphates and primers were heated in buffer to 95°C for
5 min before Taq DNA polymerase (Perkin-Elmer Cetus) was
added to the reaction mixture and reaction started in a
thermocycler (Model 480, Perkin-Elmer Cetus). The tempera-
tures of the reaction mixture were cycled 35 times through
95'C denaturation (30 s), 55'C annealing (30 s) and 72'C
extension (1 min) with a 10 min incubation at 72'C at the end.
Positive and negative control DNAs were always included in
every polymerase chain reaction (PCR) assay. Portions of the
amplified reaction mixture were separated by electrophoresis
in 2% agarose gel, with pGEM-3 DNAs digested with a
mixture of restriction endonucleases (HinJI, RsaI and SinI)
serving as size standards. HPV positivity was determined by
the presence of 450 bp amplified HPV DNA by visual inspec-
tion under ultraviolet light after staining with ethidium
bromide. Typing of HPV DNA was achieved by restriction
endonuclease digestion (Lungu et al., 1992) and by hybridisa-
tion to type-specific internal oligonucleotide (Pao et al.,
1991a, b). Adequacy and suitability of DNA for the amplifi-
cation reactions were ensured by the amplification of a
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1.455 bp portion of the human P-globin gene DNA (Pao et
al.. 1993).
Precautions against contamination andfalse-positive results in
PCR
Because of the immense sensitivity of the PCR. every precau-
tion was taken to minimise the possibility of contamination
during sampling and subsequent processing (Pao et al.,
1991a. b). Steps were also taken to minimise sample-to-
sample contamination and PCR product carry-over in order
to avoid false-positive results. These precautions include ali-
quoting of all reagents. physical separation of pre- and post-
PCR reactions and use of disposable containers whenever
possible. Furthermore, all reagents were irradiated with ultra-
violet light to inactivate any contaminated double-stranded
DNA before sample DNA was added and the PCR started.
Fifty nanograms of human DNA or 1 ng of E. coli DNA was
used as a negative control, which always yielded negative
results. Multiple reagent controls were also included in each
PCR assay and gave negative results. Repeated DNA
amplification assays of the same specimens at different times
produced the same results.
Results
The determination of the presence of HPV DNA sequences
by PCR with consensus primers MYO9 and MYl1 is illus-
trated in Figure 1. The sensitivity of this method of detecting
HPV types 16 and 18 DNA was determined to be less than
200 HPV genome equivalents based on amplification of
either serial dilutions of purified cloned HPV DNA of known
concentrations or of DNA prepared from CaSki and HeLa
cells (data not shown). The adequacy of DNA available for
amplification and the fact that DNA prepared from speci-
mens obtained from Taiwan and LueYang were equally
efficient for amplification were ensured by the ability to
amplify a 1.455 bp portion of human P-globin gene (data not
shown).
DNA sequences homologous to that of HPV were found
in cervical carcinoma tissues of Chinese patients living both
in Taiwan and in LueYang of Shanxi province (Table I). The
HPV DNA-positive rates were 88.5% (54 of 61) and 57.1%
(28 of49) among these two groups of Chinese cervical cancer
patients respectively. Forty-six of 54 of the HPV-positive
specimens from Taiwan and 21 of 28 HPV-positive specimens
from LueYang contained either type 16 or 18 DNA.
No visible correlation can be found between the HPV
positivity and either the age of the patients at the time of
diagnosis or the pathology and stages of the cervical car-
cinomas (data not shown).
Discussio
HPV DNA sequences, predominantly the high-risk types of
16 and 18. were found very frequently in cervical carcinomas.
Depending on the methods of detection used, HPV 16 and 18
DNA sequences were found in up to 90% of cervical car-
cinomas (Gissman. 1984; Brescia et al.. 1986; Pfister, 1987;
Xiao et al.. 1988: Arends et al.. 1990; Lorincz et al.. 1992).
Furthermore. immortalisation of primary genital epithelial
cells in vitro by HPV 16 and 18 requires the expression of E6
and E7 oncoproteins of these viruses (Hawley-Nelson et al.,
1989). Some oncoprotein genes are also retained and ex-
pressed in cervical carcinomas and carcinoma-derived cell
lines (Schneider-Gadicke & Schwarz. 1986; Smotkin & Wett-
stein. 1986). Despite all these reports, definitive proof of a
causal role for HPV in cervical carcinoma is currently lack-
ing. There is still controversy regarding the role of HPV in
cervical malignancies. The small number of cervical car-
cinomas negative for HPV DNA may be genuinely unrelated
to HPV infection or may contain other yet undetermined
Figure 1 Agarose gel electrophoresis of amplified HPV DNA
using consensus primers and the conditions described in the
Materials and methods section. pGEM-3 DNA digested with a
mixture of restriction endonucleases (Hinfl. RsaI and Sinl) was
used as size standards in lanes A and J. and the sizes are (from
top to bottom) 2.645. 1.605. 1.198. 676. 517. 460. 396. 350. 222.
179. 126. 75. 65. 51 and 36 bp. Lanes B and C are the
amplification of DNA from purified cloned HPV types 6 and 11
DNA respectively. Lanes D (HPV positive) and E (HPV
negative) are the amplification of DNA from cervical cancer
tissue sections from two patients. Lane F is the amplification of
DNA from finger-like papillomatosis lesions from one patient
(HPV negative). Lane G is the amplification of 50 ng of human
DNA with the HPV consensus primers MY09 and MY II. Lanes
H and I are the amplification of CaSki and HeLa cells. respec-
tivelv. which are known to contain HPV types 16 and 18 respec-
tively.
Table I HPV in Chinese cervical carcinoma patients living in





Per cent positive 88.5 57.1
HPV. or low copy numbers of viral DNA which, so far, have
proven difficult to detect. On the other hand. because of the
use of extremely sensitive PCR. HPV DNA has been found
in a substantial percentage of cervical smears of women
without cytological evidence of abnormalities (Young et al..
1989: Nakazawa et al.. 1992). The role these so-called 'sub-
clinical' HPV may play. if any. in the development ofcervical
malignancies is unclear.
The reasons for the relatively low HPV prevalence in
LueYang is not known at the present time. but it is not
completely surprising because almost all of the residents in
LueYang live all their lives in conservative. farming com-
munities with puritanical mores. This low HPV prevalence in
cervical carcinomas from LueYang cannot be explained by
the use of different detection methods because all of our
specimens were analysed in the same laboratory using the
same primers and amplification conditions. Low HPV preva-
lence in cervical carcinomas in LueYang may be clinically
important because 90% of cervical carcinomas from
Chengdu in Sichuan province, which is not too far from
LueYang. were found to contain DNA related to HPV 16
and or 18 (Xiao et al.. 1988). It has to be stated, though, that
we cannot completely rule out the possibility that HPV other
than the more than 40 types that could be detected by the
primers we used might be responsible for. or involved in. the696 C.C. PAO et al.
carcinogenesis of cervical carcinomas in LueYang. However.
if this is the case, then this putative HPV would have to
infect as frequently as. if not more frequently than, HPV 16
and 18 did in cervical carcinomas reported elsewhere. So far.
no HPV has been found in cervical carcinomas more fre-
quently than types 16 and 18. Kjaer et al. (1993) recently
reported that, using both DNA hybridisation and PCR
methods, they could find no significant difference in HPV
prevalence between cervical carcinoma patients from high-
risk and low-risk areas.
There is presently no explanation for the relatively low
HPV prevalence in a population with extremely high cervical
carcinoma incidence in China. Host factors are among the
possible causes that might have contributed to this extremely
high incidence of cervical carcinoma in LueYang. It is not
impossible that these residents are genetically predisposed to
be at-risk for cervical carcinoma owing to mutational altera-
tions in certain host genes that possess tumour-suppressive
activities. This notion is in accordance with the fact that
LueYang is an isolated inland farming community and local
residents very frequently marry residents from within the
same community. Studies are also currently under way to
determine whether transient recently acquired versus chronic
persistent HPV infections may exist in these two patient
populations which may have a different outcome with regard
to the development of cervical malignancies.
Whatever the underlying reasons for the extremely high
cervical carcinoma incidence in LueYang, our results seem to
suggest that HPV may not be the only factor that determines
the development of cervical carcinoma. at least in certain
geographical areas. Cervical carcinomas in these patients may
provide us with an excellent opportunity to examine the
possible role of host factors. including tumour-suppressor
genes, in the carcinogenesis of cervical carcinoma.
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